Patent ID: 6930112

Claim:
A method for inhibiting epileptogenesis, comprising administering to a subject in need thereof an effective amount of a compound represented by the formula: R 9a , R 9b , R 10a , R 10b are each independently hydrogen, an alkyl, alkenyl, alkynyl aryl, alkoxy, aryloxy, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, amino, hydroxy, thiol, alkylthiol, nitro, cyano, halogen, carboxyl, alkoxycarbonyloxy, aryloxycarbonyloxy, or aminocarbonyl group, or one of R 9a and R 9b and one of R 10a and R 10b are both taken together and form a double bond; or R 9a and R 9b , together with the two-carbon unit to which they are attached, are joined to form a carbocyclic or heterocyclic ring having from 4 to 8 members in the ring; R 10a and R 10b , together with the two-carbon unit to which they are attached, are joined to form a carbocyclic or heterocyclic ring having from 4 to 8 members in the ring; or one of R 9a and R 9b is joined with one of R 10a and R 10b , together with the two-carbon unit to which they are attached, to form a carbocyclic or heterocyclic ring having from 4 to 8 members in the ring; R 11 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, or aryloxycarbonyl; or one of R 10b and R 10b is joined with R 11 , together with the carbon atom and nitrogen atom to which they are respectively attached, to form a heterocyclic ring having from 4 to 8 members in the ring; and R 12 is selected from the group consisting of hydrogen, alkyl, aryl and a carbohydrate; or a pharmaceutically acceptable salt thereof; such that epileptogenesis is inhibited.